Earnings Call · Q2 FY2021·2021-08-04

Q2 21EPS +14.63%·Rev n/aQ1 21EPS +27.50%·Rev n/aQ4 20EPS -13.79%·Rev n/aQ3 20EPS +3.57%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations

Chad Robins — Co-founder and Executive Chairman

Julie Rubinstein — Chief Commercial Officer

Chad Cohen — Chief Financial Officer

+3.8%1d on move date+4.3% vs SPY3d−1.9%5d−4.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access